High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation
- 30 September 1989
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 34 (3) , 294-298
- https://doi.org/10.1016/0090-8258(89)90161-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Distant metastases in epithelial ovarian carcinomaCancer, 1987
- Etoposide (VP-16-213) plus cis-diamminedichloroplatinum as salvage therapy in advanced epithelial ovarian cancerGynecologic Oncology, 1987
- Phase II trial of vinblastine in previously treated patients with ovarian cancer: A Southwest Oncology Group studyGynecologic Oncology, 1987
- Hexamethylmelamine in ovarian cancer after failure of cisplatin-based multiple-agent chemotherapyGynecologic Oncology, 1987
- COMPLETE REMISSION AT LAPAROTOMY: STILL A GOLD STANDARD IN OVARIAN CANCER?The Lancet, 1986
- Second-look laparotomy in managing epithelial ovarian carcinomaCancer, 1986
- A critical reassessment of second-look laparotomy in epithelial ovarian carcinomaCancer, 1986
- Ovarian carcinoma: A decade of progressCancer, 1984
- High-dose chemotherapy with autologous bone marrow transplantationCancer, 1984
- Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancerGynecologic Oncology, 1984